Healthcare • Diagnostics & Research
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if BNR is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
3 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
17 filers reported a long position in BNR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Kynam Capital Management, LP | $10.5M | 1.2M | +0.9% |
| CRCM LP | $1.8M | 212K | -24.8% |
| RENAISSANCE TECHNOLOGIES LLC | $442.3K | 52.8K | +49.2% |
| MORGAN STANLEY | $364.9K | 43.6K | +185.5% |
| Amova Asset Management Americas, Inc. | $257.7K | 29.7K | -1.4% |
| Sumitomo Mitsui Trust Group, Inc. | $248.8K | 29.7K | -1.4% |
| BANK OF AMERICA CORP /DE/ | $244.1K | 29.2K | Unchanged |
| CITADEL ADVISORS LLC | $236.6K | 27.3K | +54.4% |
| UBS Group AG | $150K | 17.9K | +4,291.2% |
| Almanack Investment Partners, LLC. | $135.6K | 16.2K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.